|
JK07 Clinical Trials
2 actively recruiting trials across 2 locations
Pipeline
Phase 2: 2
Top Sponsors
- Salubris Biotherapeutics Inc2
Indications
- Heart Disease2
- Group 2 Pulmonary Hypertension1
- Heart Failure With Reduced Ejection Fraction1
- Heart Failure With Preserved Ejection Fraction1
- HFpEF - Heart Failure With Preserved Ejection Fraction1
Alexander City, Alabama1 trial
Phase 2
Tulsa, Oklahoma1 trial
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
Saint Francis Heart and Vascular Institute
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.